Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Meridien Research
2543
mi
from 98109
Bradenton, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Meridien Research
2543
mi
from 98109
Bradenton, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Sarkis Clinical Trials
2450
mi
from 98109
Gainesville, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Sarkis Clinical Trials
2450
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Suncoast Clinical Research, Inc.
2501
mi
from 98109
New Port Richey, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Suncoast Clinical Research, Inc.
2501
mi
from 98109
New Port Richey, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
2483
mi
from 98109
Ocala, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
2483
mi
from 98109
Ocala, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Psychiatric Inst of Florida-Clinical Neuroscience Solutions
2547
mi
from 98109
Orlando, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Psychiatric Inst of Florida-Clinical Neuroscience Solutions
2547
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Compass Research
2548
mi
from 98109
Oviedo, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Compass Research
2548
mi
from 98109
Oviedo, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Accord Clinical Research
2534
mi
from 98109
Port Orange, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Accord Clinical Research
2534
mi
from 98109
Port Orange, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Roskamp Institute
2549
mi
from 98109
Sarasota, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Roskamp Institute
2549
mi
from 98109
Sarasota, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Infinity Clinical Reserach . LLC
2709
mi
from 98109
Sunrise, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Infinity Clinical Reserach . LLC
2709
mi
from 98109
Sunrise, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Premiere Research Institute at Palm Beach Neurology
2688
mi
from 98109
West Palm Beach, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Premiere Research Institute at Palm Beach Neurology
2688
mi
from 98109
West Palm Beach, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research, Inc.
399
mi
from 98109
Meridian, ID
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research, Inc.
399
mi
from 98109
Meridian, ID
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Healthcare Research Network - Blue Island
1737
mi
from 98109
Blue Island, IL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Healthcare Research Network - Blue Island
1737
mi
from 98109
Blue Island, IL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research Center
1879
mi
from 98109
Anderson, IN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research Center
1879
mi
from 98109
Anderson, IN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Investigative Clinical Research of Indiana, LLC
1866
mi
from 98109
Elwood, IN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Investigative Clinical Research of Indiana, LLC
1866
mi
from 98109
Elwood, IN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Midwest Institute for Clinical Research
1862
mi
from 98109
Indianapolis, IN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Midwest Institute for Clinical Research
1862
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Deaconess Clinic
1874
mi
from 98109
Newburgh, IN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Deaconess Clinic
1874
mi
from 98109
Newburgh, IN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Integrated Clinical Trial Services, Inc.
1457
mi
from 98109
West Des Moines, IA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Integrated Clinical Trial Services, Inc.
1457
mi
from 98109
West Des Moines, IA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Phoenix Medical Research
1507
mi
from 98109
Prairie Village, KA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Phoenix Medical Research
1507
mi
from 98109
Prairie Village, KA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Otri-Med Corporation
1966
mi
from 98109
Edgewood, KY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Otri-Med Corporation
1966
mi
from 98109
Edgewood, KY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
L-MARC Research Center
1944
mi
from 98109
Louisville, KY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
L-MARC Research Center
1944
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Pharmasite Research
2320
mi
from 98109
Baltimore, MD
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Pharmasite Research
2320
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Boston Clinical Trials, INC.
2485
mi
from 98109
Boston, MA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Boston Clinical Trials, INC.
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Michigan Head Pain & Neurological Institute
1903
mi
from 98109
Ann Arbor, MI
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Michigan Head Pain & Neurological Institute
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute Inc.
1391
mi
from 98109
Minneapolis, MN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute Inc.
1391
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinvest
1635
mi
from 98109
Springfield, MO
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinvest
1635
mi
from 98109
Springfield, MO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Healthy Perspectives Innovative Mental Health Services, PL
2454
mi
from 98109
Nashua, NH
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Healthy Perspectives Innovative Mental Health Services, PL
2454
mi
from 98109
Nashua, NH
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Albuquerque Clinical Trials
1184
mi
from 98109
Albuquerque, NM
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Albuquerque Clinical Trials
1184
mi
from 98109
Albuquerque, NM
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Dent Neurological Institute
2111
mi
from 98109
Amherst, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Dent Neurological Institute
2111
mi
from 98109
Amherst, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Central New York Clinical Research
2240
mi
from 98109
Manlius, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Central New York Clinical Research
2240
mi
from 98109
Manlius, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
NYU Langone
2402
mi
from 98109
New York, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
NYU Langone
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Fieve Clincial Services
2402
mi
from 98109
New York, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Fieve Clincial Services
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
2160
mi
from 98109
Rochester, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
2160
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Metrolina Neurological Associates, PA
2284
mi
from 98109
Charlotte, NC
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Metrolina Neurological Associates, PA
2284
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Rapid Medical Research, Inc.
2029
mi
from 98109
Cleveland, OH
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Rapid Medical Research, Inc.
2029
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Medical College of Ohio at Toledo
1929
mi
from 98109
Toledo, OH
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Medical College of Ohio at Toledo
1929
mi
from 98109
Toledo, OH
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Healthcare Research Consultant
1564
mi
from 98109
Tulsa, OK
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Healthcare Research Consultant
1564
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Summit Research Network
146
mi
from 98109
Portland, OR
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Summit Research Network
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Lehigh Center for Clinical Research
2335
mi
from 98109
Allentown, PA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Lehigh Center for Clinical Research
2335
mi
from 98109
Allentown, PA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Preferred Primary Care Physicians, Inc
2132
mi
from 98109
Pittsburgh, PA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Preferred Primary Care Physicians, Inc
2132
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Abington Neurological Associates
2369
mi
from 98109
Willow Grove, PA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Abington Neurological Associates
2369
mi
from 98109
Willow Grove, PA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Omega Medical Research
2486
mi
from 98109
Warwick, RI
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Omega Medical Research
2486
mi
from 98109
Warwick, RI
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of South Carolina
2412
mi
from 98109
Charleston, SC
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of South Carolina
2412
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
8 Medical Park
2322
mi
from 98109
Columbia, SC
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
8 Medical Park
2322
mi
from 98109
Columbia, SC
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
ClinSearch, LLC
2090
mi
from 98109
Chattanooga, TN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
ClinSearch, LLC
2090
mi
from 98109
Chattanooga, TN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
University of Tennessee Medical Center
2113
mi
from 98109
Knoxville, TN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
University of Tennessee Medical Center
2113
mi
from 98109
Knoxville, TN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Associates
1971
mi
from 98109
Nashville, TN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Associates
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials
1765
mi
from 98109
Austin, TX
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials
1765
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Protenium Clinical Research
1661
mi
from 98109
Hurst, TX
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Protenium Clinical Research
1661
mi
from 98109
Hurst, TX
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
1779
mi
from 98109
San Antonio, TX
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
1779
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Radiant Research - San Antonio
1779
mi
from 98109
San Antonio, TX
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Radiant Research - San Antonio
1779
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials